Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Borer

Showing results (181-190 of 394) with videos related to

Pageof 40
Sort By:
The American Journal of Medicine|October 1, 1979
The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literatureJ E Parrillo, J S Borer, W L Henry, et al.
Cardiology|October 21, 1998
Fibrosis, myocyte degeneration and heart failure in chronic experimental aortic regurgitationS K Liu, N R Magid, P R Fox, et al.
Heart Failure Clinics|April 24, 2007
Cellular and molecular basis of remodeling in valvular heart diseasesJeffrey S Borer, Edmund McM Herrold, John N Carter, et al.
Journal of Orthopaedic Trauma|May 25, 2006
Cephalomedullary nails in the treatment of high-energy proximal femur fractures in young patients: a prospective, randomized comparison of trochanteric versus piriformis fossa entry portalAdam J Starr, Michael T Hay, Charles M Reinert, et al.
Cardiology|November 3, 2007
Similarities and differences in design considerations for cell therapy and pharmacologic cardiovascular clinical trialsRichard M Lewis, David J Gordon, Philip A Poole-Wilson, et al.
The New England Journal of Medicine|January 2, 1975
Reduction of ischemic injury by nitroglycerin during acute myocardial infarctionS E Epstein, K M Kent, R E Goldstein, et al.
European Journal of Heart Failure|May 24, 2016
Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFTMichel Komajda, Luigi Tavazzi, Karl Swedberg, et al.
American Journal of Therapeutics|July 29, 1999
Safety of prostaglandin E1 for the treatment of peripheral arterial occlusive disease in patients with congestive heart failure. The Alprostadil InvestigatorsL Reisin, A Marmor, B Rabinowitz, et al.
Journal of the American College of Cardiology|March 1, 1983
Digital subtraction intravenous left ventricular angiography: comparison with conventional intraventricular angiographyH L Goldberg, J S Borer, J W Moses, et al.
Contemporary Clinical Trials|July 6, 2010
Academic perspectives on the United States Food and Drug Administration's guidance for industry on diabetes mellitusCharles H Hennekens, Patricia R Hebert, Wendy R Schneider, et al.
Pageof 40

Showing results (181-190 of 394) with videos related to

Sort By:
Pageof 40
The American Journal of Medicine|October 1, 1979
The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literatureJ E Parrillo, J S Borer, W L Henry, et al.
Cardiology|October 21, 1998
Fibrosis, myocyte degeneration and heart failure in chronic experimental aortic regurgitationS K Liu, N R Magid, P R Fox, et al.
Heart Failure Clinics|April 24, 2007
Cellular and molecular basis of remodeling in valvular heart diseasesJeffrey S Borer, Edmund McM Herrold, John N Carter, et al.
Journal of Orthopaedic Trauma|May 25, 2006
Cephalomedullary nails in the treatment of high-energy proximal femur fractures in young patients: a prospective, randomized comparison of trochanteric versus piriformis fossa entry portalAdam J Starr, Michael T Hay, Charles M Reinert, et al.
Cardiology|November 3, 2007
Similarities and differences in design considerations for cell therapy and pharmacologic cardiovascular clinical trialsRichard M Lewis, David J Gordon, Philip A Poole-Wilson, et al.
The New England Journal of Medicine|January 2, 1975
Reduction of ischemic injury by nitroglycerin during acute myocardial infarctionS E Epstein, K M Kent, R E Goldstein, et al.
European Journal of Heart Failure|May 24, 2016
Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFTMichel Komajda, Luigi Tavazzi, Karl Swedberg, et al.
American Journal of Therapeutics|July 29, 1999
Safety of prostaglandin E1 for the treatment of peripheral arterial occlusive disease in patients with congestive heart failure. The Alprostadil InvestigatorsL Reisin, A Marmor, B Rabinowitz, et al.
Journal of the American College of Cardiology|March 1, 1983
Digital subtraction intravenous left ventricular angiography: comparison with conventional intraventricular angiographyH L Goldberg, J S Borer, J W Moses, et al.
Contemporary Clinical Trials|July 6, 2010
Academic perspectives on the United States Food and Drug Administration's guidance for industry on diabetes mellitusCharles H Hennekens, Patricia R Hebert, Wendy R Schneider, et al.
Pageof 40